MAPT and tauopathy: Elucidation of the differences between pathological PTMs in the Tau protein that leads to its fibrillar polymeric form is fundamental to understanding the pathogenesis and differential diagnosis between the different tauopathies, representing a critical challenge for therapeutics [21].